Awm Investment Company Has Cut Its Lemaitre Vascular (LMAT) Position, Matson, Inc. (MATX) Had 0 Analysts Last Week

June 19, 2017 - By Linda Rogers

Awm Investment Company Inc decreased Lemaitre Vascular Inc. (LMAT) stake by 8.55% reported in 2016Q4 SEC filing. Awm Investment Company Inc sold 71,509 shares as Lemaitre Vascular Inc. (LMAT)’s stock rose 25.80%. The Awm Investment Company Inc holds 765,105 shares with $19.39 million value, down from 836,614 last quarter. Lemaitre Vascular Inc. now has $515.25 million valuation. The stock rose 1.56% or $0.42 reaching $27.67. About 1,912 shares traded. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 101.07% since June 19, 2016 and is uptrending. It has outperformed by 84.37% the S&P500.

Among 3 analysts covering Matson (NYSE:MATX), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Matson had 4 analyst reports since August 5, 2015 according to SRatingsIntel. Stifel Nicolaus downgraded Matson, Inc. (NYSE:MATX) rating on Tuesday, November 8. Stifel Nicolaus has “Hold” rating and $38 target. The stock of Matson, Inc. (NYSE:MATX) has “Mkt Perform” rating given on Monday, November 9 by FBR Capital. The rating was maintained by Stifel Nicolaus on Wednesday, August 5 with “Buy”. The rating was initiated by Seaport Global on Thursday, December 15 with “Neutral”. See Matson, Inc. (NYSE:MATX) latest ratings:

Investors sentiment decreased to 1 in 2016 Q4. Its down 0.05, from 1.05 in 2016Q3. It turned negative, as 15 investors sold Matson, Inc. shares while 59 reduced holdings. 22 funds opened positions while 52 raised stakes. 35.39 million shares or 1.16% more from 34.98 million shares in 2016Q3 were reported. 9,244 are held by Hsbc Holding Public Limited Com. Employees Retirement Association Of Colorado, a Colorado-based fund reported 1,730 shares. State Board Of Administration Of Florida Retirement Sys accumulated 32,580 shares. Blackrock Grp stated it has 0% of its portfolio in Matson, Inc. (NYSE:MATX). Moreover, Mason Street Advisors Ltd Liability has 0.01% invested in Matson, Inc. (NYSE:MATX). Swiss National Bank & Trust has 17,900 shares. Nationwide Fund Advsrs holds 0% of its portfolio in Matson, Inc. (NYSE:MATX) for 32,407 shares. Regions, Alabama-based fund reported 30,083 shares. Glenmede Trust Communication Na holds 641,368 shares or 0.12% of its portfolio. Da Davidson And Company reported 1,950 shares or 0% of all its holdings. Commonwealth Equity Serv invested 0% in Matson, Inc. (NYSE:MATX). Invest Counselors Of Maryland Limited Co holds 0.98% of its portfolio in Matson, Inc. (NYSE:MATX) for 523,970 shares. Utd Serv Automobile Association holds 17,780 shares. Ls Invest Limited Liability Company holds 1,653 shares or 0% of its portfolio. Clearbridge Llc has 284,793 shares for 0.23% of their portfolio.

Since March 2, 2017, it had 1 buy, and 3 selling transactions for $779,648 activity. Another trade for 4,300 shares valued at $147,654 was sold by CHUN MICHAEL J. COX MATTHEW J sold 20,000 shares worth $643,102. KURIYAMA STANLEY M had bought 3,300 shares worth $98,175 on Wednesday, May 17. On Monday, May 8 the insider BAIRD W BLAKE sold $87,067.

About 5,161 shares traded. Matson, Inc. (NYSE:MATX) has declined 5.12% since June 19, 2016 and is downtrending. It has underperformed by 21.82% the S&P500.

Analysts await LeMaitre Vascular Inc (NASDAQ:LMAT) to report earnings on July, 26. They expect $0.17 earnings per share, up 21.43% or $0.03 from last year’s $0.14 per share. LMAT’s profit will be $3.17 million for 40.69 P/E if the $0.17 EPS becomes a reality. After $0.16 actual earnings per share reported by LeMaitre Vascular Inc for the previous quarter, Wall Street now forecasts 6.25% EPS growth.

Awm Investment Company Inc increased Castlight Health Inc. (NYSE:CSLT) stake by 96,932 shares to 496,932 valued at $2.46 million in 2016Q4. It also upped Infusystem Holdings Inc. (NYSEMKT:INFU) stake by 641,013 shares and now owns 2.05M shares. Neophotonics Corporation (NYSE:NPTN) was raised too.

Since February 27, 2017, it had 0 insider purchases, and 9 insider sales for $8.92 million activity. $132,380 worth of LeMaitre Vascular Inc (NASDAQ:LMAT) was sold by Roberts David B on Friday, March 10. $73,717 worth of stock was sold by Wijas Michael T on Thursday, June 1. LeMaitre George W sold $639,176 worth of LeMaitre Vascular Inc (NASDAQ:LMAT) on Tuesday, May 16. Kamke Trent G also sold $477,822 worth of LeMaitre Vascular Inc (NASDAQ:LMAT) shares.

Investors sentiment decreased to 1.12 in Q4 2016. Its down 0.44, from 1.56 in 2016Q3. It is negative, as 11 investors sold LMAT shares while 39 reduced holdings. 18 funds opened positions while 38 raised stakes. 10.81 million shares or 0.20% more from 10.78 million shares in 2016Q3 were reported. Renaissance Technology Ltd Liability Corporation has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Amer Inc reported 7,765 shares. The Pennsylvania-based Susquehanna Intll Grp Llp has invested 0% in LeMaitre Vascular Inc (NASDAQ:LMAT). Schwab Charles Investment Mngmt accumulated 33,362 shares. Bessemer Inc reported 27,400 shares. Awm has invested 3.8% in LeMaitre Vascular Inc (NASDAQ:LMAT). Blackrock Gru Ltd holds 0% or 6,220 shares. Geode Mngmt Limited Liability Corporation has 100,626 shares for 0% of their portfolio. Mckinley Cap Limited Liability Delaware holds 144,610 shares. Parametric Port Assocs Lc holds 75,603 shares. Sheets Smith Wealth Management holds 0.17% or 23,522 shares in its portfolio. Morgan Stanley owns 174,023 shares for 0% of their portfolio. Grandeur Peak Advsr Ltd Company accumulated 155,827 shares or 0.72% of the stock. Bahl Gaynor reported 43,265 shares. Prudential Finance Inc stated it has 95,310 shares or 0% of all its holdings.

Among 10 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. LeMaitre Vascular had 24 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Mkt Perform” rating given on Wednesday, February 22 by Barrington Research. The rating was maintained by Benchmark with “Buy” on Wednesday, July 29. The firm has “Buy” rating given on Monday, December 7 by Dougherty & Company. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) earned “Buy” rating by Stifel Nicolaus on Friday, December 4. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) has “Neutral” rating given on Wednesday, January 20 by Sidoti. The firm has “Neutral” rating by Sidoti given on Thursday, September 22. Cowen & Co maintained the stock with “Outperform” rating in Thursday, April 21 report. TH Capital maintained the stock with “Buy” rating in Monday, December 7 report. Roth Capital maintained the stock with “Buy” rating in Monday, December 7 report. The firm has “Mkt Perform” rating given on Thursday, September 10 by Barrington Research.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: